<DOC>
	<DOCNO>NCT00535392</DOCNO>
	<brief_summary>Keppra injection approve US adjunctive therapy treatment partial onset seizure adult epilepsy . The objective current study ass safety , tolerability , pharmacokinetics , formulation child age 4 16 year .</brief_summary>
	<brief_title>Open-label Study Levetiracetam Intravenous Infusion Children ( 4-16 Years Old ) With Epilepsy</brief_title>
	<detailed_description>The primary objective study evaluate safety tolerability levetiracetam intravenous 15-minute infusion administer every 12 hour , either adjunctive treatment monotherapy child ( 4 16 year old ) epilepsy ( except status epilepticus ) , either switch equivalent levetiracetam oral dose administration new antiepileptic treatment . The evaluation period consider one complete set 4 Pharmacokinetic ( PK ) sample maximum 4 day ; - For child already take levetiracetam oral tablet oral solution prior enter study , levetiracetam intravenous ( LEV IV ) dose equivalent ( mg-for-mg ) oral dose . The first intravenous ( IV ) infusion administer 12 hour last oral dose levetiracetam . - For child take levetiracetam oral tablet oral solution prior enter study : - If weight &lt; 50 kg : dose levetiracetam intravenous ( LEV IV ) dose calculate basis weight 20 mg/kg/day ( i.e . 10 mg/kg twice daily ) . - If weight ≥ 50 kg : dose levetiracetam intravenous ( LEV IV ) 1000 mg/day ( i.e . 500 mg twice daily ) . However , necessary safety subject investigator deem appropriate levetiracetam intravenous ( LEV IV ) dose could modify one day . Subjects hospitalize duration levetiracetam IV treatment .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Male female 4 16 year age , inclusive The subject suffers epilepsy ( except status epilepticus ) The subject require levetiracetam IV treatment place oral therapy short period time The subject difficult venous accessibility History status epilepticus 3 month prior visit 1 . The subject take felbamate visit 1 take past .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Child</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra®</keyword>
	<keyword>Infusion</keyword>
	<keyword>Intravenous</keyword>
</DOC>